FindTrial
Sign In

Gene editing of human immune cell-derived iPS cells and production of immune cells

Gene editing of human immune cell-derived iPS cells and production of immune cells - Gene editing of human immune cell-derived iPS cells and production of immune cells

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058295
Enrollment
10
Registered
2025-06-26
Start date
2022-07-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gene editing of human immune cell-derived iPS cells and production of immune cells

Interventions

Blood collection from healthy donors

Sponsors

RIKEN
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: with consent

Exclusion criteria

Exclusion criteria: Not applicable

Countries

Japan

Contacts

Public ContactAoki Takahiro

Chiba Univerisy Medical Immunology

aokitakahiro@chiba-u.jp043-226-2828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026